EUVIMEDEUVIMED entdecken
Crossref

Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blocker

Ahmed Shawky, Sameh Saber, Eman M Abd El-Kader, Hassan A El-Kashef

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ahmed Shawky und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Hauptthemen laut MEDLINE: Verapamil, NLR Family, Pyrin Domain-Containing 3 Protein, Colitis, Ulcerative, Calcium Channel Blockers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a long-term inflammatory bowel disease (IBD) associated with significant morbidity. It is marked by inflammation and damage to the colon's mucosal lining. Studies have shown that NLRP3 inflammasome activation, apoptosis, and impaired autophagy are critical in its pathogenesis. Verapamil, a calcium channel blocker, has been found to inhibit NLRP3 inflammasome activation in various preclinical models. However, the potential influence of verapamil on the TXNIP in UC remains unexplored. This study investigates the effects of verapamil on an UC rat model induced chemically by acetic acid. Verapamil effectively inhibited the TXNIP-NLRP3-caspase-1 axis, reducing inflammasome activation and the release of IL-1β and IL-18. Additionally, verapamil suppressed NFκB, the priming step of NLRP3 activation. The drug enhanced autophagic activity, as indicated by increased expression of LC3-II and Beclin-1, along with reduced LC3-I and mTOR expression. Moreover, it demonstrated anti-apoptotic effects mediated by regulating Bax and cleaved caspase-3. These molecular changes contributed to mucosal healing and improved microscopic and macroscopic outcomes in the colitis model. Furthermore, verapamil improved the colon weight-to-length ratio and disease activity scores and mitigated oxidative stress. As verapamil has been safely used in clinics to treat hypertension, our findings suggest it may be a safe therapeutic option for ameliorating inflammation and apoptosis and activating autophagy in UC pathology. Since hypertension demonstrates a strong association with UC, the use of verapamil merits particular attention in hypertensive patients fighting against IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VerapamilNLR Family, Pyrin Domain-Containing 3 ProteinColitis, UlcerativeCalcium Channel BlockersInflammasomesCarrier ProteinsAnti-Inflammatory AgentsAnimalsDisease Models, AnimalMaleRatsRats, Sprague-DawleyColonAutophagyHumansApoptosisOxidative StressCell Cycle Proteins

Stichwörter der Autor:innen

InflammationNFκBTXNIP/NLRP3Ulcerative colitisVerapamil

Substanzen

VerapamilNLR Family, Pyrin Domain-Containing 3 ProteinCalcium Channel BlockersInflammasomesNlrp3 protein, ratCarrier ProteinsTXNIP protein, ratAnti-Inflammatory AgentsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt.
  • Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Electronic address: sameh.saber@deltauniv.edu.eg.
  • Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Electronic address: eman.abdelqader@deltauniv.edu.eg.
  • Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Eg…

Zitieren

APA

Shawky, A., Saber, S., Abd El-Kader, E. M., & El-Kashef, H. A. (2025). Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blocker. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114751

Vancouver

Shawky A, Saber S, Abd El-Kader EM, El-Kashef HA. Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blocker. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114751

BibTeX
@article{Shawky2025,
  author = {Shawky, Ahmed and Saber, Sameh and Abd El-Kader, Eman M and El-Kashef, Hassan A},
  title = {Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blocker},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114751}
}
Kostenlos starten →